Oncolytics Biotech Inc. Stock Nasdaq
Equities
CA6823101077
Biotechnology & Medical Research
Sales 2024 * | 857K 626K | Sales 2025 * | 6.68M 4.87M | Capitalization | 110M 80.39M |
---|---|---|---|---|---|
Net income 2024 * | -36M -26.28M | Net income 2025 * | -40M -29.2M | EV / Sales 2024 * | 128 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 16.5 x |
P/E ratio 2024 * |
-3.29
x | P/E ratio 2025 * |
-3.32
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.84% |
Latest transcript on Oncolytics Biotech Inc.
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
1st Jan change | Capi. | |
---|---|---|
-0.02% | 42.11B | |
+48.94% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |